###begin article-title 0
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 104 112 <span type="species:ncbi:9606">Children</span>
HIV-1 with Multiple CCR5/CXCR4 Chimeric Receptor Use Is Predictive of Immunological Failure in Infected Children
###end article-title 0
###begin p 1
###xml 193 201 <span type="species:ncbi:9606">children</span>
###xml 584 592 <span type="species:ncbi:9606">children</span>
Conceived and designed the experiments: GS. Performed the experiments: MC IK. Analyzed the data: MC GS. Wrote the paper: MC EMF ADR GS. Performed testing with the U87 cell lines of some of the children early isolates and contributed with her expertise on the U87 cell lines expressing chimeric receptors: IK. Performed the blood sample preparation and virus isolation of part of the samples: MZ. Has produced the U87 cells expressing the chimeric receptors and provided the cells as well as the know-how to the study: LA. Provided part of the samples and clinical data of mothers and children: AP CG. Provided part of the samples: ADR.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 220 225 220 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 135 140 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 281 286 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 409 414 <span type="species:ncbi:9606">child</span>
###xml 438 443 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 R5 viruses are characterized by a large phenotypic variation, that is reflected by the mode of coreceptor use. The ability of R5 HIV-1 to infect target cells expressing chimeric receptors between CCR5 and CXCR4 (R5broad viruses), was shown to correlate with disease stage in HIV-1 infected adults. Here, we ask the question whether phenotypic variation of R5 viruses could play a role also in mother-to-child transmission (MTCT) of HIV-1 and pediatric disease progression.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 312 318 312 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 345 350 345 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 439 444 439 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 641 646 641 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 689 694 689 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 857 862 857 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 960 965 960 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 62 67 <span type="species:ncbi:9606">women</span>
###xml 134 142 <span type="species:ncbi:9606">children</span>
###xml 247 252 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 284 291 <span type="species:ncbi:9606">infants</span>
###xml 732 737 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Viral isolates obtained from a total of 59 HIV-1 seropositive women (24 transmitting and 35 non transmitting) and 28 infected newborn children, were used to infect U87.CD4 cells expressing wild type or six different CCR5/CXCR4 chimeric receptors. HIV-1 isolates obtained from newborn infants had predominantly R5narrow phenotype (n = 20), but R5broad and R5X4 viruses were also found in seven and one case, respectively. The presence of R5broad and R5X4 phenotypes correlated significantly with a severe decline of the CD4+ T cells (CDC stage 3) or death within 2 years of age. Forty-three percent of the maternal R5 isolates displayed an R5broad phenotype, however, the presence of the R5broad virus was not predictive for MTCT of HIV-1. Of interest, while only 1 of 5 mothers with an R5X4 virus transmitted the dualtropic virus, 5 of 6 mothers carrying R5broad viruses transmitted viruses with a similar broad chimeric coreceptor usage. Thus, the maternal R5broad phenotype was largely preserved during transmission and could be predictive of the phenotype of the newborn's viral variant.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 24 29 24 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 169 175 169 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 135 143 <span type="species:ncbi:9606">children</span>
###xml 158 163 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 282 287 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our results show that R5broad viruses are not hampered in transmission. When transmitted, immunological failure occurs earlier than in children infected with HIV-1 of R5narrow phenotype. We believe that this finding is of utmost relevance for therapeutic interventions in pediatric HIV-1 infection.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 259 262 259 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-UNAIDS1">[1]</xref>
###xml 10 15 <span type="species:ncbi:9606">child</span>
###xml 39 74 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 119 127 <span type="species:ncbi:9606">children</span>
###xml 191 199 <span type="species:ncbi:9606">children</span>
Mother-to-child transmission (MTCT) of human immunodeficiency virus type 1 (HIV-1) is the primary mode of infection in children. In year 2007, an estimated 420.000 new infections occurred in children aged less than 15 years, most living in Sub-Saharan Africa [1].
###end p 9
###begin p 10
###xml 180 183 180 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti1">[2]</xref>
###xml 455 458 455 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Ometto1">[3]</xref>
###xml 460 463 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Salvatori1">[4]</xref>
###xml 161 166 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Several maternal parameters, including advanced clinical stage, low CD4+ T cell counts, high plasma viral load were associated with an increased risk of MTCT of HIV-1 (reviewed in [2]). There are controversial data concerning the role of viral phenotype in transmission. Although viruses using CXCR4 as coreceptor (X4 phenotype) can be transmitted when present in the mother, CCR5-using viruses (R5 phenotype) are the most frequently detected in newborns [3], [4].
###end p 10
###begin p 11
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Bjorndal1">[5]</xref>
###xml 118 121 118 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti2">[6]</xref>
###xml 440 443 440 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson1">[7]</xref>
###xml 445 448 445 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Koot1">[8]</xref>
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 104 112 <span type="species:ncbi:9606">children</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
Evolution of HIV-1 coreceptor use during disease progression has been demonstrated in adults as well as children [5], [6]. The evolution usually involves change from CCR5 use (R5 phenotype) to CXCR4 use alone (X4) or in combination with CCR5 (R5X4) and/or other minor coreceptors (multitropic viruses). CXCR4-using viruses can be isolated prior to or during progression to AIDS, however only from about one-half of patients with overt AIDS [7], [8], thus suggesting that R5 viruses obtained during clinical progression may differ in phenotypic characteristics from those obtained during the early stages of infection.
###end p 11
###begin p 12
###xml 111 114 111 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Peters1">[9]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Schuitemaker1">[10]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Tuttle1">[11]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Ometto2">[12]</xref>
###xml 201 204 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti2">[6]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Jansson1">[13]</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Koning1">[14]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson2">[15]</xref>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson3">[16]</xref>
###xml 553 558 553 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 626 630 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson2">[15]</xref>
###xml 651 656 651 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson2">[15]</xref>
###xml 1022 1027 1022 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 1042 1048 1042 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 1058 1062 1058 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson2">[15]</xref>
###xml 618 625 <span type="species:ncbi:9606">patient</span>
###xml 1178 1183 <span type="species:ncbi:9606">women</span>
###xml 1213 1218 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Phenotypic variation characterizes R5 viruses, as demonstrated by their varying capacity to infect macrophages [9], [10], [11], [12] or their differential susceptibility to inhibition by CC-chemokines [6], [13], [14]. Studies on the entry of R5 viruses into cells expressing CCR5/CXCR4 chimeric receptors [15], [16] showed that the differential susceptibility to inhibition by CC-chemokines depends on the mode of CCR5 use. In particular, it has been shown that during disease progression R5 viruses evolve to multiple chimeric receptor usage (called R5broad), which in turn correlated with CD4+ T cell decline in the patient [15]. Evolution of the R5broad phenotype was associated with decreased sensitivity to inhibition by the CC-chemokine RANTES [15]. The ability of a viral isolates to use one or more chimeric receptors is most probably a reflection of a more efficient usage of the CCR5 molecule, as suggested by our previous results demonstrating a higher infectivity of the wild-type CCR5 expressing cells with R5broad compared to R5narrow isolates [15]. In this study we asked the question whether phenotypic variation, implying different mode of CCR5 use in pregnant women could play a role in MTCT of HIV-1 and in turn, also in pediatric disease progression.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and virus isolation
###end title 14
###begin p 15
###xml 603 606 603 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Salvatori1">[4]</xref>
###xml 608 611 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti2">[6]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti3">[17]</xref>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti4">[18]</xref>
###xml 789 792 789 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Ometto1">[3]</xref>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Mok1">[19]</xref>
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 63 68 <span type="species:ncbi:9606">women</span>
###xml 127 135 <span type="species:ncbi:9606">children</span>
###xml 164 169 <span type="species:ncbi:9606">child</span>
###xml 221 229 <span type="species:ncbi:9606">children</span>
###xml 352 357 <span type="species:ncbi:9606">child</span>
###xml 493 498 <span type="species:ncbi:9606">child</span>
###xml 556 561 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 674 679 <span type="species:ncbi:9606">child</span>
###xml 940 948 <span type="species:ncbi:9606">children</span>
###xml 1191 1199 <span type="species:ncbi:9606">children</span>
###xml 1375 1380 <span type="species:ncbi:9606">women</span>
###xml 1405 1413 <span type="species:ncbi:9606">children</span>
Our study population included a total of 59 HIV-1 seropositive women (24 transmitting and 35 non transmitting) and 28 infected children. Viral isolates from mother-child pairs were available in 21 cases. Additional seven children were included in the study, but the maternal samples were not available. Samples from non transmitting mothers and mother-child pairs were collected within the framework of two separate cohort studies in Northern Italy. One cohort consisted of 15 infected mother-child pairs and 17 non transmitting mothers who took part in a HIV-1 MTCT multicenter study from 1989 to 1994 [4], [6], [17], [18]. The second cohort consisted of 9 infected mother-child pairs and 18 non transmitting mothers collected in the framework of MTCT multicenter study beginning in 1986 [3], [19]. All samples were from Italian subjects and collected before the introduction of any MTCT preventive antiretroviral therapy. In 14 out of 16 children tested the infection was possibly acquired during the intrapartum period, since negative results were obtained by polymerase chain reaction (PCR) within the first week of life. Postnatal transmission was excluded in all cases, as none of the children was breast-fed. The Ethical Committee approved the use of samples according to national laws (in 1986, 1991 and 2008). An informed oral consent was obtained from the pregnant women and, in the case of the children, from the parents.
###end p 15
###begin p 16
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Control1">[20]</xref>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Control2">[21]</xref>
###xml 649 652 649 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Ometto1">[3]</xref>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti3">[17]</xref>
###xml 26 31 <span type="species:ncbi:9606">women</span>
###xml 42 50 <span type="species:ncbi:9606">children</span>
###xml 135 143 <span type="species:ncbi:9606">children</span>
###xml 660 665 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 743 748 <span type="species:ncbi:9606">women</span>
The clinical stage of the women and their children (available for 21 transmitting and 24 non transmitting mothers and for 26 out of 28 children respectively), was defined according to the guidelines of the Centers for Disease Control (CDC) [20], [21]. Most of the mothers were asymptomatic at the time of virus isolation, with the exception of three mothers: one non transmitting (clinical stage B, A206) and two transmitting mothers, one with moderate symptoms (clinical stage B, A225) and one with AIDS (clinical stage C, A130). CD4+ T cell counts were provided with the samples in many cases (for 17 transmitting and 28 non transmitting mothers) [3], [17]. HIV-1 p24 antigenemia and plasma viral load were available for a limited number of women (33 and 17 mothers, respectively) and thus, were not included in the study analysis.
###end p 16
###begin p 17
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti4">[18]</xref>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-DeRossi1">[22]</xref>
###xml 213 220 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003292-t001">Table 1</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 23 31 <span type="species:ncbi:9606">children</span>
###xml 125 133 <span type="species:ncbi:9606">children</span>
###xml 223 231 <span type="species:ncbi:9606">Children</span>
###xml 348 356 <span type="species:ncbi:9606">children</span>
###xml 387 395 <span type="species:ncbi:9606">children</span>
HIV-1 infection of the children was determined by virus isolation and PCR [18], [22]. Clinical and immunological data of the children were obtained throughout follow-up, i.e. until death or for at least 10 years (Table 1). Children were treated only with mono or dual antiretroviral therapy (ART). Highly active ART (HAART) was not administered to children in groups 1, 2 and 3, whereas children in group 4 were treated only after entering CDC category 3 or C.
###end p 17
###begin title 18
###xml 61 64 61 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt101">(a)</xref>
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 53 61 <span type="species:ncbi:9606">children</span>
Clinical and viral characteristics of HIV-1 infected children(a).
###end title 18
###begin p 19
symbol - means that the event has not occurred. n.a. = not available. Mos means months of age. Age of appearance of the different conditions is always indicated in months.
###end p 19
###begin p 20
Narrow and broad refer to viruses with R5 phenotype. Viruses able to exclusively use wild type CCR5 receptor are defined narrow, whereas those using chimeric receptors besides the wild type CCR5 are defined broad. In parenthesis is indicated the age in months of the virus phenotype determination.
###end p 20
###begin p 21
###xml 43 48 43 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 92 100 <span type="species:ncbi:9606">children</span>
###xml 122 130 <span type="species:ncbi:9606">children</span>
Statistical analysis: Influence of virus R5broad phenotype on disease progression including children of group 1 and 2, or children of group 1, 2 and 3: p = 0.0260 and p = 0.0218 (Pearson's chi Square), respectively.
###end p 21
###begin p 22
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Control2">[21]</xref>
Age of entry into clinical or immunological category. Categories are defined according to the Centers for Disease Controls [21]: CDC 3 = severe immune suppression; CDC B = moderate clinical manifestations; CDC C = severe clinical manifestations.
###end p 22
###begin p 23
Age of start of mono or dual antiretroviral therapy, not HAART.
###end p 23
###begin p 24
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti4">[18]</xref>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-DeRossi1">[22]</xref>
###xml 330 337 330 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003292-t002">Table 2</xref>
###xml 35 42 <span type="species:ncbi:9606">patient</span>
###xml 87 92 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 373 381 <span type="species:ncbi:9606">children</span>
Virus isolation was performed from patient's PBMCs as previously described [18], [22]. HIV-1 p24 antigen (Ag) positive culture supernatants, collected during first or second culture passage, were used to prepare virus stocks. Maternal viral isolates were collected during pregnancy, at delivery or within 5 months after delivery (Table 2). Virus was isolated from infected children at an age range between birth and 9 months.
###end p 24
###begin title 25
###xml 44 49 <span type="species:ncbi:9606">child</span>
Comparison of viral phenotypes of 21 mother-child pairs.
###end title 25
###begin p 26
###xml 35 40 <span type="species:ncbi:9606">child</span>
###xml 126 134 <span type="species:ncbi:9606">children</span>
Isolates from corresponding mother-child pairs are indicated by the same number preceded by a letter: A for mothers and B for children. Time of sampling is indicated in parenthesis as months before (-), after (+) or within 1 week from (0) delivery/birth.
###end p 26
###begin p 27
###xml 93 99 93 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 111 116 111 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
Pairs were grouped according to the mother's virus phenotype, i.e. first those carrying an R5narrow, than an R5broad and last an R5X4 virus.
###end p 27
###begin p 28
Samples were used to infect U87.CD4 cells expressing wild type CCR5 or CXCR4, or one of the chimeric receptors FC-1, FC-2, FC-4b, FC-5, FC-6 or FC-7. Experiments were repeated twice. -, means no chimeric receptor is used.
###end p 28
###begin title 29
Infection of U87.CD4 cell lines expressing wild type and CCR5/CXCR4 chimeric receptors
###end title 29
###begin p 30
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti2">[6]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson3">[16]</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Antonsson1">[23]</xref>
###xml 584 592 584 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003292-g001">Figure 1</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
Virus stocks were used to infect human glioma U87.CD4 cells stably expressing the wild type chemokine receptors CCR5 or CXCR4, or the six CCR5/CXCR4 chimeric receptors as previously described [6], [16]. Chimeric receptors were obtained by replacing, beginning from the N-terminal, successively larger parts of CCR5 with corresponding parts of CXCR4 [23]. In the resulting chimeras CXCR4 comprised gradually larger parts: the N-terminal tail only (FC-1), including the first transmembrane portion (FC-2), the first (FC-4b), second (FC-5 and FC-6) and third (FC-7) extracellular loops (Figure 1). Parental U87.CD4 cells, engineered to express CD4 but no chemokine receptor, were used as negative control.
###end p 30
###begin title 31
Schematic representation of the chemokine receptors CCR5 and CXCR4 and the chimeric CCR5/CXCR4 receptors.
###end title 31
###begin p 32
Chimeric receptors FC-1, FC-2, FC-4b, FC-5, FC-6 and FC-7 were obtained by replacing successively larger parts of CCR5 with corresponding regions of CXCR4.
###end p 32
###begin p 33
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Moore1">[24]</xref>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 410 415 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cells were infected in duplicate with each virus stock containing at least 2 ng/ml HIV-1 p24 Ag. The cultures were kept for 7 days and inspection for syncytia formation was performed at days 1, 3 and 7. Supernatant was collected on day 1, after washing, and at the last day of infection, and tested for the presence of p24 Ag by an in-house ELISA assay [24] (). Cultures were only considered for evaluation if HIV-1 p24 value at day 1 was below the lower detection limit of the assay. Viral antigen production was considered positive when the absorbance at day 7 exceeded 0.2 Optical Density (O.D.).
###end p 33
###begin p 34
###xml 76 82 76 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 219 224 219 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson2">[15]</xref>
Viruses able to use only the wild type CCR5 as coreceptor were defined as R5narrow, whereas R5 viruses able to use the chimeric receptors, FC-1, FC-2, and FC-4b singularly or in different combinations were defined as R5broad, according to the previously published classification [15]. R5X4 viruses used the six chimeric receptors in different combinations, and were not further classified.
###end p 34
###begin title 35
Statistical analysis
###end title 35
###begin p 36
###xml 73 81 <span type="species:ncbi:9606">children</span>
Correlation between R5 phenotype and immunological CDC stage of infected children were analyzed by Pearson's chi-square test. Comparison of the frequencies of the wild type chemokine receptor and chimeric receptor usage in the two groups of mothers was done by Fisher's Exact test and Pearson's chi-square test. The Mann-Whitney test and Pearson's chi-square test were used to compare the level of CD4+ T cell counts in the two groups of mothers. Analysis of variance (ANOVA) was performed to demonstrate the association between CD4+ T cell values and viral phenotype. Pearson's chi-square test was used to determine the correlation between clinical stage and the transmission status of mothers. Values below 0.05 were regarded as statistically significant.
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
###xml 13 18 13 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 with R5broad phenotype can be transmitted
###end title 38
###begin p 39
###xml 317 320 317 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Ometto1">[3]</xref>
###xml 432 438 432 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 539 544 539 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 547 554 547 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003292-t001">Table 1</xref>
###xml 603 608 603 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 289 294 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 339 347 <span type="species:ncbi:9606">children</span>
###xml 465 473 <span type="species:ncbi:9606">children</span>
###xml 655 663 <span type="species:ncbi:9606">children</span>
Virus isolates obtained close to birth from 28 newborns were analyzed for phenotypic variability in a cell line expressing wild type or chimeric chemokine receptors. CXCR4 using virus was isolated from one newborn only, confirming previous observations that CCR5 is preferentially used by HIV-1 early after infection [3]. Twenty out of 27 children (74.07%) with an R5 virus carried a virus able to exclusively use wild type CCR5 (R5narrow), whereas the remaining 7 children (25.93%) harboured virus with broad use of chimeric receptors (R5broad) (Table 1). These results indicate that transmission of R5broad virus occurred in a significant proportion of children even if the majority of viruses replicating at a time point close to infection are restricted to the use of wild type CCR5.
###end p 39
###begin title 40
###xml 6 11 6 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 70 78 <span type="species:ncbi:9606">children</span>
The R5broad phenotype is predictive of early immunological failure in children
###end title 40
###begin p 41
###xml 178 185 178 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003292-t001">Table 1</xref>
###xml 219 224 219 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 497 502 497 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 816 821 816 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 1026 1031 1026 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 1176 1183 1176 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003292-t002">Table 2</xref>
###xml 90 98 <span type="species:ncbi:9606">children</span>
###xml 151 156 <span type="species:ncbi:9606">child</span>
###xml 339 347 <span type="species:ncbi:9606">children</span>
###xml 657 665 <span type="species:ncbi:9606">children</span>
###xml 857 862 <span type="species:ncbi:9606">child</span>
Clinical and immunological data obtained during follow-up were available for 25 out of 27 children carrying an R5 virus close to birth and for the one child with the R5X4 virus (Table 1). The presence of viruses with R5broad phenotype in the infected newborns was accompanied by a faster progression to immunological failure. Indeed, only children who experienced a severe decline of the CD4+ T cell counts as fast as within 2 or 3 years of age or died within 1 year (groups 1, 2 and 3) carried R5broad viruses close to birth (p = 0.026 or p = 0.0218, Pearson's chi-square, including groups 1 and 2, or groups 1, 2 and 3, respectively). Whereas none of the children, who were classified as CDC category 3 after 36 months of age or did not enter this category during the follow up (groups 4 or 5), had a virus with R5broad phenotype close to birth. The only child with a R5X4 virus showed also a fast decline of the CD4+ T cell count (classified CDC 3 within 6 months of age) and died at 44 months. Specifically, all but one R5broad isolate of the newborns used FC-4b either alone (n = 2) or in combination with FC-2 (n = 4), whereas only one virus isolate used FC-1 and FC-2 (Table 2).
###end p 41
###begin title 42
Maternal viral phenotype is predictive of the newborn's virus
###end title 42
###begin p 43
###xml 259 266 259 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003292-t002">Table 2</xref>
###xml 301 307 301 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 411 416 411 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 472 477 472 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 585 591 585 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 709 714 709 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 742 748 742 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 1004 1009 1004 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 252 257 <span type="species:ncbi:9606">child</span>
###xml 318 326 <span type="species:ncbi:9606">children</span>
###xml 560 565 <span type="species:ncbi:9606">child</span>
###xml 621 626 <span type="species:ncbi:9606">child</span>
###xml 798 803 <span type="species:ncbi:9606">child</span>
###xml 965 970 <span type="species:ncbi:9606">child</span>
With the aim to understand if selective processes operate during transmission, and thus could be predictive for disease progression, we compared the phenotype of the virus isolates available from 21 mothers close to delivery with that of their newborn child (Table 2). All ten mothers harbouring an R5narrow virus had children whose virus displayed the same phenotype. Interestingly, the six mothers carrying R5broad viruses transmitted in all but one case a virus with R5broad phenotype (identical or similar to the mother's virus); in the exceptional mother-child pair, virus with R5narrow phenotype was present in the child. The five mothers with an R5X4 virus transmitted in one case R5X4, in two cases R5broad and in another two cases R5narrow virus. Looking at the details, coreceptor use of child's virus was narrower than the corresponding mother's virus in 7 out of 11 cases, identical in two cases, and a more flexible use of the CCR5 was observed in one child (pair 252). Thus, a virus with R5broad phenotype was transmitted from the majority of mothers carrying such viruses (5 out of 6; 83.3%), indicating that the maternal viral phenotype is generally preserved during transmission and can possibly be predictive of the phenotype of the newborn's viral variant.
###end p 43
###begin title 44
Maternal viral R5 phenotype is not predictive of transmission
###end title 44
###begin p 45
###xml 414 422 414 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003292-g002">Figure 2</xref>
To identify factors predictive of transmission the viral phenotype of 59 mothers (24 transmitting and 35 non transmitting) was investigated. Transmitting mothers carried more often viruses able to use both CCR5 and CXCR4 as coreceptors than non transmitting mothers, 29% (7 out of 24) and 8% (3 out of 35), respectively, but this difference did not reach statistical significance (p = 0.074, Fisher's Exact Test) (Figure 2). No mother carried a monotropic X4 virus.
###end p 45
###begin title 46
Distribution of the viral phenotype of transmitting and non transmitting mothers.
###end title 46
###begin p 47
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 137 143 137 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 162 167 162 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
Distribution of R5 (black) vs. R5X4 (white) viruses within all virus phenotypes (n = 59 viruses; p = n.s., Fisher's Exact Test) and of R5narrow (dark gray) vs. R5broad (light gray) within the R5 phenotype (n = 49 viruses; p = n.s., Fisher's Exact Test).
###end p 47
###begin p 48
###xml 79 85 79 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 246 254 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003292-g002">Figure 2</xref>
###xml 282 287 282 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 594 597 594 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 719 724 719 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
The analysis of the chimeric receptor usage showed that the frequency of the R5narrow phenotype was similar between the two groups of mothers, 53% in non transmitting and 65% in transmitting mothers (17 out of 32 and 11 out of 17, respectively) (Figure 2). Furthermore, among the R5broad isolates (15 and 6 in non transmitting and transmitting mothers, respectively), no difference was observed in the use of FC-1 and FC-2 receptors between the 2 groups of mothers, while viruses from non transmitting mothers utilized FC-4b more frequently than viruses from transmitting mothers (13 out of 15 vs. 2 out of 6, respectively) with a trend towards significance (p = 0.056, Perason's chi-square test). This suggests that R5broad viruses from non transmitting mothers can use CCR5 at least as flexibly as viruses from transmitting mothers.
###end p 48
###begin p 49
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 390 396 390 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 402 407 402 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
Analyses of other factors potentially correlated with risk of transmission disclosed that the two groups of mothers transmitting and non transmitting, could not be distinguished by the clinical stage (p = n.s., Pearson's chi-square test) and the CD4+ T cell counts (mean 478 and 426 cells/mm3; p = n.s., Mann-Whitney test). Furthermore CD4+ T cell values of mothers carrying viruses with R5narrow or R5broad phenotype did not differ (p = n.s., ANOVA), but were significantly different from those of mothers carrying CXCR4 using viruses (p = 0.0014, ANOVA). Thus the clinical and the immunological stage of the mothers did not seem to influence the risk of transmission in our cohort.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson2">[15]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson3">[16]</xref>
###xml 752 757 752 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 160 165 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 199 207 <span type="species:ncbi:9606">children</span>
###xml 216 221 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 463 468 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 805 810 <span type="species:ncbi:9606">child</span>
Biological characteristics of HIV-1 that are critical for the risk of MTCT continue to be subject to discussion. R5 is the predominant virus phenotype early in HIV-1 infection, both in adults and in children born to HIV-1-infected mothers. Since tools to test the mode of CCR5 use [15], [16] have been developed in the past years, we asked the question whether flexible use of CCR5, here dissected into narrow and broad phenotype, would influence transmission of HIV-1 and pediatric disease progression. In the present study the infected newborns harboured mostly viruses of R5 phenotype, a significant proportion (25.9%) of these was able to use chimeric receptors, suggesting that viral variants with a more flexible and efficient use of CCR5 (the R5broad phenotype) can exist close to infection in the child.
###end p 51
###begin p 52
###xml 56 61 56 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 183 188 183 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Casper1">[25]</xref>
###xml 498 503 498 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 610 615 610 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 734 738 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson2">[15]</xref>
###xml 385 390 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 400 408 <span type="species:ncbi:9606">children</span>
###xml 795 803 <span type="species:ncbi:9606">children</span>
###xml 879 884 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Of utmost relevance are our data, which show that the R5broad phenotype detected in the newborn shortly after birth was predictive of a fast and severe immunological failure. Thus, R5broad viruses seem to determine detrimental effects similar to those known for CXCR4 using viruses. These data support the finding by Casper et al, who suggested that the immunological deterioration in HIV-1 infected children precedes the viral phenotypic switch to CXCR4 usage [25]. We suggest that pre-existing R5broad viruses may have caused the worsening of the disease. Interestingly, in our study all but one newborn's R5broad virus were capable of FC-4b usage, which indeed was previously shown to be linked to evolution to CXCR4 use in adults [15]. Further studies with sequential follow up samples from children will clarify if the association with CXCR4 switch occurs also in pediatric HIV-1 infection.
###end p 52
###begin p 53
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Tuttle2">[26]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Tuttle2">[26]</xref>
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Sleasman1">[27]</xref>
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Bleul1">[28]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Mo1">[29]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Blaak1">[30]</xref>
###xml 279 284 279 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 299 305 299 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Karlsson2">[15]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Sleasman1">[27]</xref>
###xml 801 806 801 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 541 546 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 670 678 <span type="species:ncbi:9606">children</span>
###xml 922 930 <span type="species:ncbi:9606">children</span>
In neonates the memory CD4+ T cells, which express high levels of CCR5, are 6-7 times less represented than the naive CD4+ cells [26]. The latter predominantly express CXCR4 [26], [27], [28], [29], and are primarily infected by CXCR4 using viruses [30]. It is likely, that the R5broad compared to R5narrow viruses may infect CD4+ naive cells in addition to memory cells despite the limited expression of the CCR5 molecule, due to their more efficient usage of the coreceptor [15]. Interestingly, Sleasman et al. [27] described that although HIV-1 infected neonates in general contained 10 to 100 fold greater number of infected CD4+ memory cells than naive cells, those children who rapidly progressed in the disease had high proviral load in the CD4+ naive cells. Thus, infection of naive cells by R5broad viruses may interfere with CD4+ T cells production, and thus account for the rapid disease progression observed in children harbouring these viruses. It remains to be solved why CXCR4 using viruses are not preferentially maintained during transmission, despite the high prevalence of CXCR4+ naive cells in neonates.
###end p 53
###begin p 54
###xml 411 417 411 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 421 426 421 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 516 521 516 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 90 95 <span type="species:ncbi:9606">child</span>
The detailed analysis of the mother's viruses in comparison to those of the corresponding child allowed us once again to pinpoint that the R5 phenotype, either narrow or broad, was usually maintained during the transmission event. On the contrary, the R5X4 phenotype was predominantly lost during transmission. Specifically, mothers with an R5X4 virus transmitted virus with a whole array of phenotypes, i.e. R5narrow, R5broad or R5X4. These data lend further support to the lack of restriction in transmission of R5broad viruses and favour the possibility that the maternal viral R5 phenotype is predictive of the transmitted variant.
###end p 54
###begin p 55
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Scarlatti3">[17]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Pasquier1">[31]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Wolinsky1">[32]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-Ometto3">[33]</xref>
Our data suggest that mothers carrying R5X4 viruses have phenotypically highly heterogenous populations. Whether a selective process or simply a random event governs transmission remains, however, a topic of discussion. [17], [31], [32], [33].
###end p 55
###begin p 56
###xml 36 41 36 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 123 128 123 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003292-MeddowsTaylor1">[34]</xref>
###xml 762 767 762 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 924 929 924 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 936 942 936 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 976 981 976 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broad</sup>
###xml 1055 1061 1055 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">narrow</sup>
###xml 110 115 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 170 175 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 818 823 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We showed that mothers harbouring R5broad viruses were not at higher risk of transmission and the presence of HIV-1 with R5broad phenotype was not predictive for MTCT of HIV-1. The use of chimeric receptors suggests a more flexible usage of CCR5, which in turn may indicate increased viral resistance to inhibition by CC-chemokines. In this respect, the trend of the non transmitting mothers to more often carry viruses with the specific usage of the FC-4b chimeric receptor than transmitting mothers, is intriguing. Recently, Meddows-Taylor et al. described that non transmitting mothers have significantly higher levels of CCL3 in the plasma than transmitting mothers [34]. It could be envisaged that high levels of CCL3 may be needed to efficiently inhibit R5broad viruses and, as a consequence, to prevent MTCT of HIV-1. In this respect, it will be relevant to compare the level of CC-chemokines in mothers harbouring R5broad and R5narrow viruses as well as to study if R5broad viruses have a lower sensitivity to the new CCR5 inhibiting drugs than R5narrow viruses.
###end p 56
###begin p 57
###xml 385 393 <span type="species:ncbi:9606">children</span>
###xml 497 502 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In summary our data show that approximately one forth of the newborn's R5 viruses have the capacity to use CCR5/CXCR4 chimeric receptors indicating that phenotypes with increased flexibility of co-receptor use are not hampered during transmission. Conversely these viral variants are significantly linked with severe immunological failure within the first years of age of the infected children. These data may have important implications for timely and appropriate therapeutic choice in pediatric HIV-1 infection.
###end p 57
###begin p 58
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 349 352 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 366 374 <span type="species:ncbi:9606">Children</span>
###xml 410 418 <span type="species:ncbi:9606">children</span>
The samples were provided by the National Care System for HIV-1 infected mothers, the Seventh Department of Gynecology and Obstetrics, and the First and Fourth Department of Pediatrics of the University of Milan, Italy and by the AIDS Reference Center, Unit of Viral Oncology, University of Padova, Italy. The authors thank the Italian Register for HIV Infection in Children for providing clinical data of the children.
###end p 58
###begin p 59
The statistical analysis was kindly performed by Clelia Di Serio and Alessandro Ambrosi from the University Centre of Statistics for Biomedical Sciences, Vita Salute San Raffaele University, Milan, Italy.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
###xml 10 15 <span type="species:ncbi:9606">child</span>
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries.
###end article-title 61
###begin article-title 62
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 90 95 <span type="species:ncbi:9606">child</span>
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission.
###end article-title 62
###begin article-title 63
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 49 54 <span type="species:ncbi:9606">child</span>
HIV type 1 chemokine receptor usage in mother-to-child transmission.
###end article-title 63
###begin article-title 64
###xml 28 63 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
###end article-title 64
###begin article-title 65
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
###end article-title 65
###begin article-title 66
###xml 66 101 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection.
###end article-title 66
###begin article-title 67
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
###end article-title 67
###begin article-title 68
###xml 22 57 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.
###end article-title 68
###begin article-title 69
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
###end article-title 69
###begin article-title 70
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 142 150 <span type="species:ncbi:9606">children</span>
Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.
###end article-title 70
###begin article-title 71
###xml 15 18 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
###end article-title 71
###begin article-title 72
###xml 94 99 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.
###end article-title 72
###begin article-title 73
###xml 204 239 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection.
###end article-title 73
###begin article-title 74
###xml 67 102 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.
###end article-title 74
###begin article-title 75
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
###end article-title 75
###begin article-title 76
###xml 16 51 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 75 80 <span type="species:ncbi:9606">child</span>
Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype.
###end article-title 76
###begin article-title 77
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 106 114 <span type="species:ncbi:9606">children</span>
Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children.
###end article-title 77
###begin article-title 78
###xml 0 7 <span type="species:ncbi:9606">Infants</span>
###xml 41 69 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Infants born to mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicentre European study.
###end article-title 78
###begin article-title 79
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.
###end article-title 79
###begin article-title 80
###xml 39 67 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 81 89 <span type="species:ncbi:9606">children</span>
1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age.
###end article-title 80
###begin article-title 81
###xml 128 133 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Antigen detection, virus culture, polymerase chain reaction, and in vitro production in the diagnosis of vertically transmitted HIV-1 infection.
###end article-title 81
###begin article-title 82
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4.
###end article-title 82
###begin article-title 83
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
###end article-title 83
###begin article-title 84
###xml 68 76 <span type="species:ncbi:9606">children</span>
###xml 101 106 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes.
###end article-title 84
###begin article-title 85
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 128 135 <span type="species:ncbi:9606">infants</span>
Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents.
###end article-title 85
###begin article-title 86
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 97 105 <span type="species:ncbi:9606">children</span>
CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children.
###end article-title 86
###begin article-title 87
###xml 4 7 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
###end article-title 87
###begin article-title 88
###xml 27 30 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Expression patterns of the HIV type 1 coreceptors CCR5 and CXCR4 on CD4+ T cells and monocytes from cord and adult blood.
###end article-title 88
###begin article-title 89
###xml 8 13 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.
###end article-title 89
###begin article-title 90
###xml 33 38 <span type="species:ncbi:9606">child</span>
###xml 113 148 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1.
###end article-title 90
###begin article-title 91
###xml 26 54 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 87 94 <span type="species:ncbi:9606">infants</span>
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.
###end article-title 91
###begin article-title 92
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 94 99 <span type="species:ncbi:9606">child</span>
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission.
###end article-title 92
###begin article-title 93
###xml 101 131 <span type="species:ncbi:11676">human immunodeficiency virus 1</span>
Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission.
###end article-title 93
###begin p 94
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 94
###begin p 95
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The financial support was received by the Swedish Research Council and by the Istituto Superiore di Sanita within the framework of the National program for AIDS research, Grant no.40G.21, 45G.12 and 40G.56. Only financial support.
###end p 95

